Adolphe Merkle Institute
Barbara Drasler has not added Biography.
If you are Barbara Drasler and would like to personalize this page please email our Author Liaison for assistance.
Current in vitro approaches to assess nanoparticle interactions with lung cells.
Nanomedicine (London, England) Sep, 2016 | Pubmed ID: 27529369
Comparative in vitro genotoxicity study of ZnO nanoparticles, ZnO macroparticles and ZnCl to MDCK kidney cells: Size matters.
Toxicology in vitro : an international journal published in association with BIBRA Apr, 2017 | Pubmed ID: 28126643
Quantifying nanoparticle cellular uptake: which method is best?
Nanomedicine (London, England) 05, 2017 | Pubmed ID: 28447906
Respiratory hazard assessment of combined exposure to complete gasoline exhaust and respirable volcanic ash in a multicellular human lung model at the air-liquid interface.
Environmental pollution (Barking, Essex : 1987) Jul, 2018 | Pubmed ID: 29455917
Carbon nanodots: Opportunities and limitations to study their biodistribution at the human lung epithelial tissue barrier.
Biointerphases 09, 2018 | Pubmed ID: 30205690
Polydopamine/Transferrin Hybrid Nanoparticles for Targeted Cell-Killing.
Nanomaterials (Basel, Switzerland) Dec, 2018 | Pubmed ID: 30562983
On the issue of transparency and reproducibility in nanomedicine.
Nature nanotechnology Jul, 2019 | Pubmed ID: 31270452
Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.
Nature nanotechnology Aug, 2019 | Pubmed ID: 31289407
Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.
Nature nanotechnology Sep, 2019 | Pubmed ID: 31358944
Assessment of the potential for in-plume sulphur dioxide gas-ash interactions to influence the respiratory toxicity of volcanic ash.
Environmental research 12, 2019 | Pubmed ID: 31629947
Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model.
Nanomedicine (London, England) 02, 2020 | Pubmed ID: 31789097
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。